Sayaka Kozuki

Sayaka Kozuki

Auto-generated profile, based on publicly available information

Sayaka Kozuki

Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, USA

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2026 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
GLGerrald A Lodewijk
Gerrald A Lodewijk
BTBenjamin R Topacio
Benjamin R Topacio
SLSeungho Lee
Seungho Lee
SKSayaka Kozuki
Sayaka Kozuki
AAAlexis Abigail A Alburo
Alexis Abigail A Alburo
SSS Ali Shariati
S Ali Shariati
Quiescent cells repress cell-cycle genes via chromatin-based mechanisms to maintain a non-dividing state, yet remain poised to reenter the cell cycle upon stimulation. E2F1, a canonical activator of cell-cycle genes, is sufficient to induce cell-cycle reentry from quiescence, but how it overcomes chromatin-mediated repression remains unclear. Here, we show that inducible E2F1 expression triggers exit from quiescence without changes in chromatin accessibility by harnessing regulatory elements with limited accessibility. Time-resolved transcriptomic analysis demonstrates that E2F1 induces an accelerated transcriptional program compared to serum stimulation. Unlike serum, which triggers broad chromatin remodeling, E2F1 activates genes within a chromatin context with limited accessibility. ChIP-seq analyses reveal that E2F1 binds target sites in quiescent cells to activate canonical cell-cycle genes. Biochemical reconstitution demonstrates that E2F1 binds nucleosomes and accesses DNA wrapped by histones. These findings suggest that E2F1 accesses nucleosome-associated DNA and initiates transcription without major chromatin reorganization. Our work redefines the relationship between transcription factor and chromatin dynamics during fate transitions and establishes E2F1 as a potent regulator capable of inducing cell-cycle reentry without changing chromatin accessibility.